Electric Pace-pitched Hearing Achieves Natural Tonotopy
ELEPHANT
1 other identifier
interventional
30
1 country
1
Brief Summary
In search of the best possible outcome for the severe hearing impaired who have regained the ability to hear by means of a cochlear implant (CI), electrical stimulation and the information it carries should match as closely as possible to what the human brain naturally has evolved to cope with and learned to process instead of relying on plasticity to adapt to an induced mismatch. At the moment, however, CI's are fitted with a 'one size fits all' principle. This is known to cause a mismatch between the frequencies presented by the CI electrode array and the frequencies represented at the corresponding natural acoustic location in an individual cochlea. In this study it is hypothesized that an individual imaged based fitting that pursues natural hearing alignment and is implemented from the start of the rehabilitation process, will improve the individual outcomes of electric hearing. The natural fitting strategy is thought to give rise to a steeper learning curve, result in a better performance in challenging listening situations, improve sound quality, complement better with residual acoustic hearing in the contralateral ear and win the preference of CI-recipients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 18, 2019
CompletedFirst Submitted
Initial submission to the registry
March 20, 2019
CompletedFirst Posted
Study publicly available on registry
March 27, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 18, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 18, 2021
CompletedMarch 27, 2019
March 1, 2019
2 years
March 20, 2019
March 25, 2019
Conditions
Outcome Measures
Primary Outcomes (4)
Speech understanding in quiet with cochlear implant
Speech understanding with CI in quiet measured with the Dutch Consonant Nucleus Consonant (CNC) test.
During the first 12 months of CI rehabilitation
Speech understanding in quiet with cochlear implant
Speech understanding with CI in quiet will be measured with the Dutch Matrix sentence test.
During the first 12 months of CI rehabilitation
Speech understanding in noise with cochlear implant
Speech understanding with CI in noise will be measured with the Dutch Matrix sentence test.
During the first 12 months of CI rehabilitation
Patient preference
At every fitting session, patients will be asked to rate their satisfaction with either the control or experimental program on a 10-point Visual Analog Sscale (1 dissatisfied - 10 very satisfied).
During the first 12 months of CI rehabilitation
Secondary Outcomes (10)
Speech understanding with hearing aid
During the first 12 months of CI rehabilitation
Speech understanding with hearing aid
During the first 12 months of CI rehabilitation
Spatial masking
During the first 12 months of CI rehabilitation
Listening effort
During the first 12 months of CI rehabilitation
Spectral resolution (SMRT test)
During the first 12 months of CI rehabilitation
- +5 more secondary outcomes
Study Arms (2)
Imaged based fitting
EXPERIMENTALMapping of the electrical input of the cochlear implant will be based on an individualized natural frequency alignment as estimated with imaging methods.
Clinical routine
NO INTERVENTIONMapping of the electrical input of the cochlear implant will be based on a one-size-fits-all, as is part of clinical routine.
Interventions
Mapping of the electrical input of the cochlear implant will be based on an individualized natural frequency alignment as estimated with imaging methods.
Eligibility Criteria
You may qualify if:
- Adult (18y or older) and meeting the conventional Dutch CI criteria;
- Proficient speaker of Dutch language;
- Post-lingual onset of profound deafness (\> 4 years of age);
- Subject receives an Advanced Bionics implant with Midscala electrode and an Advanced Bionics sound processor;
- Prepared to use study specific hearing aid (Phonak) for the duration of the study;
- Rehabilitation at MUMC+ for the first year after surgery regarding CI as well as HA;
- Active participation in trial related procedures such as daily randomization and regular testing.
You may not qualify if:
- Physical or non-physical contraindications for MRI or CT imaging;
- Additional disabilities that may prevent active participation and testing as per protocol. If there are indications that the mental abilities to comply with the study procedures are insufficient, additional screening will be performed with the Mini-Mental State Examination. Patients will be excluded from the study when the resulting score is lower than 24;
- Cochlear or neural abnormalities that could affect outcome measures and/or compromise the placement of the electrode as assessed by the CI surgeon;
- Active participation in another prospective clinical trial;
- Pregnancy at time of imaging;
- Requirement for electric-acoustic activation prior to the first year follow-up;
- Having received a cochlear implant earlier (e.g. explantation or bilateral implantation).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MUMC
Maastricht, Limburg, 6202 AZ, Netherlands
Related Publications (1)
Lambriks LJG, van Hoof M, Debruyne JA, Janssen M, Chalupper J, van der Heijden KA, Hof JR, Hellingman CA, George ELJ, Devocht EMJ. Evaluating hearing performance with cochlear implants within the same patient using daily randomization and imaging-based fitting - The ELEPHANT study. Trials. 2020 Jun 23;21(1):564. doi: 10.1186/s13063-020-04469-x.
PMID: 32576247DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erwin George, Dr.
Maastricht UMC+
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 20, 2019
First Posted
March 27, 2019
Study Start
March 18, 2019
Primary Completion
March 18, 2021
Study Completion
March 18, 2021
Last Updated
March 27, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share